Cargando…

pH-Sensitive Ratiometric Fluorescent Probe for Evaluation of Tumor Treatments

Determining therapeutic efficacy is critical for tumor precision theranostics. In order to monitor the efficacy of anti-cancer drugs (e.g., Paclitaxel), a pH-sensitive ratiometric fluorescent imaging probe was constructed. The pH-sensitive ratiometric fluorescent dye ANNA was covalently coupled to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Peisen, Meng, Junli, Li, Yingying, Wang, Zihua, Hou, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566363/
https://www.ncbi.nlm.nih.gov/pubmed/31109039
http://dx.doi.org/10.3390/ma12101632
_version_ 1783426835222102016
author Zhang, Peisen
Meng, Junli
Li, Yingying
Wang, Zihua
Hou, Yi
author_facet Zhang, Peisen
Meng, Junli
Li, Yingying
Wang, Zihua
Hou, Yi
author_sort Zhang, Peisen
collection PubMed
description Determining therapeutic efficacy is critical for tumor precision theranostics. In order to monitor the efficacy of anti-cancer drugs (e.g., Paclitaxel), a pH-sensitive ratiometric fluorescent imaging probe was constructed. The pH-sensitive ratiometric fluorescent dye ANNA was covalently coupled to the N-terminal of the cell-penetrating TAT peptide through an amidation reaction (TAT-ANNA). The in vitro cellular experiments determined that the TAT-ANNA probe could penetrate the cell membrane and image the intracellular pH in real time. The in vivo experiments were then carried out, and the ratiometric pH response to the state of the tumor was recorded immediately after medication. The TAT-ANNA probe was successfully used to monitor the pharmacodynamics of anti-cancer drugs in vivo.
format Online
Article
Text
id pubmed-6566363
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-65663632019-06-17 pH-Sensitive Ratiometric Fluorescent Probe for Evaluation of Tumor Treatments Zhang, Peisen Meng, Junli Li, Yingying Wang, Zihua Hou, Yi Materials (Basel) Article Determining therapeutic efficacy is critical for tumor precision theranostics. In order to monitor the efficacy of anti-cancer drugs (e.g., Paclitaxel), a pH-sensitive ratiometric fluorescent imaging probe was constructed. The pH-sensitive ratiometric fluorescent dye ANNA was covalently coupled to the N-terminal of the cell-penetrating TAT peptide through an amidation reaction (TAT-ANNA). The in vitro cellular experiments determined that the TAT-ANNA probe could penetrate the cell membrane and image the intracellular pH in real time. The in vivo experiments were then carried out, and the ratiometric pH response to the state of the tumor was recorded immediately after medication. The TAT-ANNA probe was successfully used to monitor the pharmacodynamics of anti-cancer drugs in vivo. MDPI 2019-05-18 /pmc/articles/PMC6566363/ /pubmed/31109039 http://dx.doi.org/10.3390/ma12101632 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zhang, Peisen
Meng, Junli
Li, Yingying
Wang, Zihua
Hou, Yi
pH-Sensitive Ratiometric Fluorescent Probe for Evaluation of Tumor Treatments
title pH-Sensitive Ratiometric Fluorescent Probe for Evaluation of Tumor Treatments
title_full pH-Sensitive Ratiometric Fluorescent Probe for Evaluation of Tumor Treatments
title_fullStr pH-Sensitive Ratiometric Fluorescent Probe for Evaluation of Tumor Treatments
title_full_unstemmed pH-Sensitive Ratiometric Fluorescent Probe for Evaluation of Tumor Treatments
title_short pH-Sensitive Ratiometric Fluorescent Probe for Evaluation of Tumor Treatments
title_sort ph-sensitive ratiometric fluorescent probe for evaluation of tumor treatments
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566363/
https://www.ncbi.nlm.nih.gov/pubmed/31109039
http://dx.doi.org/10.3390/ma12101632
work_keys_str_mv AT zhangpeisen phsensitiveratiometricfluorescentprobeforevaluationoftumortreatments
AT mengjunli phsensitiveratiometricfluorescentprobeforevaluationoftumortreatments
AT liyingying phsensitiveratiometricfluorescentprobeforevaluationoftumortreatments
AT wangzihua phsensitiveratiometricfluorescentprobeforevaluationoftumortreatments
AT houyi phsensitiveratiometricfluorescentprobeforevaluationoftumortreatments